🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a multicenter, randomized, observer-blinded, controlled, immune equ...
Status
Completed
Location
Lingga Health Research Center
Start Date
2020-02-04
Trial ID
NCT04204096
Treatments Being Tested
This study is a prospective cohort study to find the incidence of re-cranio...
Status
Completed
Location
Multiple Locations
Start Date
2017-01
Trial ID
NCT03910556
Treatments Being Tested
Background: GM1 gangliosidosis is a disorder that destroys nerve cells. It...
Status
Recruiting
Location
National Institutes of Health Clinical Center
Start Date
2019-08-19
Trial ID
NCT03952637
Treatments Being Tested
The aim of this study is to determine the concentrations of Visfatin, Fetui...
Status
Completed
Location
Ondokuz Mayıs University, Faculty of Dentistry, Department of Periodontology
Start Date
2021-11-15
Trial ID
NCT05662475
Study is Interventional, cross-sectional, clinical trial without drug and w...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-09
Trial ID
NCT06896201
The goal of this clinical trial is to determine if implementing a controlle...
Status
Not Yet Recruiting
Location
Kingston Health Sciences Centre
Start Date
2026-06
Trial ID
NCT07629648
Single-arm, single site, open label study of the effects of parenteral test...
Status
Completed
Location
Sibley Memorial Hospital
Start Date
2014-08-25
Trial ID
NCT02090114
Treatments Being Tested
The coprecipitation method was used to prepare hydroxypropyl-beta-cyclodext...
Status
Completed
Location
Multiple Locations
Start Date
2013-03
Trial ID
NCT02418676
Treatments Being Tested
The goal of this clinical trial is to learn if a new injectable drug (IP-00...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-05
Trial ID
NCT07321847
The investigators hypothesize that intermittent first-line Panitumumab plus...
Status
Completed
Location
Istituto Nazionale Tumori di Napoli - IRCCS - Fondazione G. Pascale
Start Date
2018-05-21
Trial ID
NCT04425239
Treatments Being Tested